David Harper

Company: Evolution Biotechnologies

Job title: CEO

Seminars:

Panel Discussion: Overcoming Barriers in Securing Funding & Questioning the Investment Process…Worth Billions or Nothing? 11:00 am

Explaining the sudden dry up of funds Learning how investors value an early-stage phage business that could make or break it Understanding what makes an attractive proposition when looking at investing in life science phage therapies How does funding capital differ for different bacteriophage therapiesRead more

day: Day Two

Discussing the Selection of Disease Targets for Bacteriophages 1:30 pm

Accessibility and suitability of the bacterial target Identification and selection of bacteriophages Commercial considerations in the selection of targetsRead more

day: Day One